Razadyne
NDC 21695-591
Product Information
Razadyne is a NDA-approved product labeled by Rebel Distributors Corp. Galantamine is used to treat mild to moderate confusion (dementia) related to Alzheimer's disease. It is supplied as a white product. This product entry covers the primary NDC 21695-591 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BROWN (C48332 - ORANGE-BROWN)
8 MM
JANSSEN;G;4
JANSSEN;G;12
Code Structure Chart
Product Details
What is NDC 21695-591?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- GALANTAMINE HYDROBROMIDE (UNII: MJ4PTD2VVW)
- GALANTAMINE (UNII: 0D3Q044KCA) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (UNII: 68401960MK)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 579148 - galantamine HBr 12 MG Oral Tablet
- RxCUI: 579148 - galantamine 12 MG Oral Tablet
- RxCUI: 579148 - galantamine 12 MG (as galantamine hydrobromide 15.379 MG) Oral Tablet
- RxCUI: 602734 - Razadyne 12 MG Oral Tablet
- RxCUI: 602734 - galantamine 12 MG Oral Tablet [Razadyne]
* Please review the full disclaimer at the bottom of this page.